Gilead’s $11.9 billion purchase of Kite Pharma in 2017 didn’t follow the script, with two big write-downs in the value of the asset since then, but a fresh approval for a CAR-T therapy could claw back ...
Amber Kite is a member of the Texas regional digital content team, based in Dallas, Texas. Amber is a native of Texas and has had a career in television news since 2001. She has led digital news teams ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results